KIMS vs RAINBOW: Stock Comparison

Krishna Institute of Medical Sciences Limited vs Rainbow Childrens Medicare Limited

Live data: 6 August 2026, 4:08 PM IST • Source: NSE and company filings

Krishna Institute of Medical Sciences Limited is the larger company by market capitalisation. Krishna Institute of Medical Sciences Limited shows faster revenue growth, while Rainbow Childrens Medicare Limited shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Krishna Institute of Medical Sciences Limited and Rainbow Childrens Medicare Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, KIMS is more favourable on 2 of 13 scored metrics and RAINBOW on 11These counts are context-free and are not an overall rating.

Key Differences

Market Cap
KIMS is the larger company
₹33,972 Cr vs ₹15,965 Cr
P/E Ratio
RAINBOW has a lower P/E
56.76x vs 158.32x
P/B Ratio
RAINBOW has a lower P/B
9.83x vs 14.26x
EPS
RAINBOW has higher earnings per share
₹27.48 vs ₹6.04
Dividend Yield
RAINBOW has a higher dividend yield
0.2% vs 0%
Revenue Growth (TTM YoY)
KIMS has faster revenue growth
34.8% vs 24.3%
EPS Growth (TTM YoY)
RAINBOW has faster EPS growth
39.1% vs -58.3%
Qtr Sales Growth
KIMS has stronger quarterly sales growth
34.8% vs 24.3%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKIMSRAINBOW
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricKIMSRAINBOW
Live Price₹808.6₹1,573.2
Day Change0.8%-1.59%
Volume5.04 L1.01 L
52-Week High₹858₹1,610
52-Week Low₹575.8₹1,084
Distance from 52W High-5.76%-2.29%

Valuation

MetricKIMSRAINBOW
Market Cap₹33,972 Cr₹15,965 Cr
P/E Ratio158.32x56.76x
P/B Ratio14.26x9.83x
EPS₹6.04₹27.48
Book Value₹56.17₹162.36
Dividend Yield0%0.2%

Growth

MetricKIMSRAINBOW
Revenue Growth (TTM YoY)34.8%24.3%
EPS Growth (TTM YoY)-58.3%39.1%
Qtr Sales Growth34.8%24.3%
Qtr Profit Growth-50.7%38.6%

Profitability & Leverage

MetricKIMSRAINBOW
ROE11.3%15.9%
ROCE9.29%17.4%
Net Margin6.18%16.34%
Operating Margin20.5%32.2%
Debt to Equity1.89x0.54x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKIMSRAINBOW
Promoter Holding32.5% 1.61 pp49.84%
FII Holding14.74% 0.17 pp16.03% 1.21 pp
DII Holding34.43% 1.93 pp22.56% 1.43 pp
Public Holding18.33% 0.49 pp11.39% 0.28 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Krishna Institute of Medical Sciences Limited and Rainbow Childrens Medicare Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.